BRD4 and colorectal carcinoma: Targeting multiple CRC constituents and SE driven downstream genes may prevent resistance or enhance sensitivity to BRD4 inhibitors, as JQ1 blocks the binding of BRD4 with acetylated histones, rather than targeting BRD4 itself, which is still recruited to SEs and contributing to phase separation of chromatin domains50.